Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2025-12-25 @ 9:57 PM
NCT ID: NCT01065558
Description: None
Frequency Threshold: 5
Time Frame: 12 days of active treatment and 28 days follow-up
Study: NCT01065558
Study Brief: Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Ecopipam Treated Patients None None None 2 5 5 5 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Respiratory Infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
Flank Pain NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (10.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Sedation NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
Dystonia NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View